Cameco Corporation (CCJ) financials
NYSE · Energy · Uranium · 3,082 employees · CEO Timothy S. Gitzel
- Price
- $76.91 -7.88%
- Market cap
- $33.5B
- Enterprise value
- CA$47B
- Last report
- Q3 '26 filed 2026-10-30
- Next report
- 2027-02-12
Valuation & key figures
- Market cap
- $33.5B EV CA$47B
- Revenue
- CA$3.46B Trailing 12 months
- Revenue growth
- +2% FY2026 consensus
- Profit margin
- 11.5% Net income / revenue, TTM
- P/E
- 117.5×
- P/S
- 13.5× Price / sales, TTM
- EV / EBITDA
- 53.9× TTM
- Free cash flow
- CA$338M Trailing 12 months
- Net income
- CA$397M Trailing 12 months
- Revenue estimate
- CA$3.54B FY2026 consensus
- Earnings
- 2027-02-12
- Dividend
- $0.17 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Revenue growth accelerating: -1.9% year on yearQ3 '26 revenue CA$603M, against an average of -3.3% over the four quarters before.
- Operating margin 12.6% (TTM), -5.4 pp on a year agoOperating income grew -30.1% while revenue grew -0.1%.
- 13.9% of pre-tax profit is non-operatingPre-tax income CA$508M vs operating income CA$438M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 12.3% of revenue (a year ago 8.3%)CA$427M invested in the last 4 quarters (+48.1% on a year earlier). Free cash flow CA$338M = 85.1% of net income.
- Returned CA$104M to shareholders = 31.0% of free cash flowBuybacks CA$0 (a year earlier CA$0), dividends CA$104M, stock-based pay CA$5.61M (TTM).
- Diluted share count up 0.0% in a year436M diluted shares in Q3 '26, 435M a year earlier.
- Net debt CA$150MCash + short-term investments CA$863M, debt incl. leases CA$1.01B; a year ago net debt CA$229M.
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | CA$603M | CA$615M | -1.9% |
| Gross margin | 16.1% | 37.3% | -21.3 pp |
| Operating income | CA$25.1M | CA$93M | -73.0% |
| Operating margin | 4.2% | 15.1% | -11.0 pp |
| Net income | CA$41.6M | -CA$141K | +29,604.2% |
| Diluted EPS | CA$0.10 | -CA$0.00 | +31,933.3% |
| Operating cash flow | -CA$52.6K | CA$156M | -100.0% |
| Capex | CA$134M | CA$92.5M | +44.5% |
| Free cash flow | -CA$134M | CA$63.2M | -311.6% |
| R&D | CA$12.5M | CA$10.3M | +21.8% |
| Stock-based compensation | CA$0 | CA$2.45M | -100.0% |
Revenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- CA$765M
- Capex
- -CA$427M
- Buybacks
- CA$0
- Dividends
- -CA$104M
- Acquisitions
- CA$179K
- Net debt issued
- -CA$2.28M
- Stock-based compensation
- CA$5.61M
- Free cash flow
- CA$338M
- Returned to shareholders / FCF
- 31.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 117.5× | 121.5× 4 of 5 years | 68.7× – 184.8× |
| EV / EBITDA | 53.9× | 46.7× | 32.5× – 72.7× |
| EV / Sales | 13.5× | 10.0× | 6.6× – 15.7× |
| Price / FCF | 152.4× | 50.2× | 30.5× – 77.2× |
| Price / Book | 6.5× | 4.3× | 2.1× – 7.9× |
| FCF yield | 0.7% | 2.2% | 1.3% – 3.3% |
| Return on invested capital | 3.5% | 1.8% | -1.9% – 4.8% |
| Return on equity | 5.6% | 3.3% | -2.1% – 8.5% |
Analysts
Consensus target $133.60 (+73.7%)
range $95.00 – $175.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | CA$3.54B | +1.8% | CA$1.40 | +3.8% | – | 6 |
| FY2027 | CA$4B | +13.1% | CA$2.55 | +81.8% | – | 12 |
| FY2028 | CA$4.35B | +8.7% | CA$3.30 | +29.4% | – | 6 |
| FY2029 | CA$4.58B | +5.2% | CA$3.99 | +20.9% | – | 9 |
| FY2030 | CA$4.82B | +5.3% | CA$5.19 | +30.1% | – | 5 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02 · Amounts in CAD as reported; price and market cap in USD.